IVF Success Rate in India: What You Need to Know

What Is IVF and How Does It Work?

In vitro fertilization (IVF) is a fertility treatment in which eggs are collected from the ovaries, fertilized with sperm in the laboratory, and the resulting embryo(s) are transferred into the uterus. A typical IVF cycle involves ovarian stimulation, egg retrieval, fertilization (with IVF or ICSI), embryo culture (often to blastocyst), and embryo transfer—either fresh or frozen. Many clinics now prefer a “freeze-all/segmented” approach in selected patients, followed by frozen embryo transfer in a hormonally prepared cycle, depending on the clinical scenario.

Success Rate of IVF in India: Overview

In most real-world Indian practice settings, success rates are commonly discussed as pregnancy rates per attempt and cumulative success over multiple attempts. Broadly, many clinics quote ~30–60% pregnancy rate per attempt (especially per embryo transfer) and ~50–80–90% cumulative pregnancy chance over repeated transfers/cycles in younger women with good ovarian reserve. Outcomes are lower in older age groups, and also fall with poor egg quality, poor sperm parameters, and suboptimal endometrium.

A key point when interpreting numbers: not all clinics report success in the same way—some report “positive pregnancy test,” others “clinical pregnancy,” and fewer report “live birth/take-home baby rate.” This makes comparisons difficult.

Which IVF Clinic Has the Highest Success Rate in India?

Unlike the UK, where the HFEA publishes clinic-level outcomes from a national regulator, India does not currently have a universally visible, independently audited, patient-verified public success-rate dashboard that allows reliable “highest success rate” rankings for every clinic. The ART (Regulation) Act, 2021 establishes a National Registry intended to capture outcomes and clinic details; however, patients should still assume that publicly advertised success rates may not be directly comparable across centres because definitions, case-mix (easy vs difficult cases), and reporting methods vary.

Practical advice: rather than asking “who is highest,” ask each clinic for live birth rate (not just pregnancy rate), age-wise results, results specifically for self-eggs, and whether they report per embryo transfer and cumulative outcomes.

Content

IVF Success Rate in India by Age

Age remains the strongest predictor of IVF outcome because egg quality (aneuploidy risk) rises with age. In many clinics, women under 35–37 may achieve around ~50–60% clinical pregnancy per embryo transfer, with cumulative pregnancy reaching ~80–90% over multiple transfers when ovarian reserve is good and embryos are available. After 37, success rates decline progressively; after 40, the drop is steeper, and more attempts are often needed.

Importantly, emerging Indian data suggests that ovarian reserve may decline earlier in some Indian women, with lower AMH being seen at younger ages among women presenting to fertility centres. This is one reason we should be careful about directly applying Western “age curves” to Indian patients and should counsel based on the individual’s ovarian reserve (AMH/AFC), not age alone.

Factors Affecting IVF Success in India

Key factors include:

• Female age (most important)
  
  
• Ovarian reserve: AMH and AFC
  
  
• Sperm quality: count, motility, morphology
  
  
• Endometrial thickness and uterine environment
  
  
• Associated conditions: fibroids (especially cavity-distorting), adenomyosis, endometriosis, PCOS, hydrosalpinx, uterine anomalies
  
  
• Previous ovarian surgery (may reduce reserve)
  
  
• Lab quality and embryo culture conditions (often under-recognized but crucial)
  

There is also evidence from large datasets that treatment outcomes can vary by ethnicity in some settings; UK regulator data has shown lower birth rates in Asian patients compared with White patients in certain age groups, reinforcing the need for individualized counseling rather than assuming identical outcomes across populations.

Tips to Improve IVF Success

1. Don’t delay too long: age drives egg quality; best outcomes are usually <37.
   
   
2. Optimize health: stop smoking, avoid excess alcohol, improve sleep, manage stress, maintain a healthy weight, and follow a balanced, protein-adequate diet with regular exercise.
   
   
3. Treat correctable factors: address hydrosalpinx, cavity issues, uncontrolled thyroid/prolactin problems, and significant fibroids/adenomyosis when indicated.
   
   
4. Personalize protocols: stimulation and transfer planning should match ovarian reserve, response history, and uterine factors.
   
   
5. Use add-ons selectively, not routinely: techniques such as assisted hatching, adhesion embryo transfer aids (“embryo glue”), and immunomodulation are sometimes used in selected situations, but should be based on the individual’s history rather than as default “packages.”
   
   
6. PGT-A is not for everyone: major professional guidance states that routine universal PGT-A for all IVF patients cannot be recommended, and randomized trials have not consistently shown improved live birth for younger women.
7. ERA is not for everybody: recent higher-quality evidence has shown that ERA-guided personalized embryo transfer does not reliably improve live birth rates, and may not be helpful as a routine test, even after prior failures—so it should be reserved for carefully selected cases, if at all.
   

References 

1. Practice Committee of the American Society for Reproductive Medicine. The use of preimplantation genetic testing for aneuploidy: a committee opinion. Fertil Steril. 2024.
   
   
2. Practice Committee of the American Society for Reproductive Medicine. Clinical management of mosaic results from PGT-A of blastocysts: a committee opinion. Fertil Steril. 2023.
   
   
3. Cozzolino M, Diáz-Gimeno P, Pellicer A, Garrido N. Use of the endometrial receptivity array to guide personalized embryo transfer and live birth outcomes. Fertil Steril. 2022;118(4):724–736.
   
   
4. Arian SE, Hessami K, Khatibi A, et al. Endometrial receptivity array before frozen embryo transfer cycles: systematic review and meta-analysis. Fertil Steril. 2023;119(2):229–238.
   
   
5. Malhotra N, et al. Anti-Mullerian hormone levels in Indian women seeking infertility treatment: are Indian women facing early ovarian senescence? J Hum Reprod Sci. 2022.
   
   
6. Human Fertilisation and Embryology Authority (HFEA). Latest ethnic diversity data highlights disparities in treatment outcomes (2020–21).
   
   
7. Government of India. The Assisted Reproductive Technology (Regulation) Act, 2021. India Code (Official).